Join
Live feed
·
PRReleasevia Quantisnow
Statera Biopharma Inc. logo
Tivic Health Systems Inc. logo

Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

ByQuantisnow·Wall Street's wire, on your screen.
STAB· Statera Biopharma Inc.TIVC· Tivic Health Systems Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STAB (Statera Biopharma Inc.), TIVC (Tivic Health Systems Inc.) and more on Quantisnow.